BiotechBreakouts.com Review – Kyle Dennis Exceeds $3M in Trading Profits

---

What is BiotechBreakouts.com, Who is Kyle Dennis, and How Has He Made Over $3,000,000?

BiotechBreakouts.com is a leading educational platform and interactive community for stock traders. Within the stock trading space, these types of programs are often referred to as “newsletters” or “advisories”.

But before you go thinking that this is just another alert service that constantly sends out trade ideas without any explanation, let me be clear that this service isn’t like that. The primary focus is on education, which allows members to eventually become self-sufficient and consistently profitable as they learn to discover, track, and evaluate today’s hottest biotech stocks on their own.

Kyle Dennis is the founder of Biotech Breakouts and is one of the best active traders on Wall Street, hands down. Even at just 27 years old, he’s exponentially more qualified to teach biotech trading to his members due to his unmatched success. In less than five years, he’s taken a modest $15,000 starting portfolio and turned it into over $3,000,000.

I’ll give you a minute to name another trader that has been able to generate a similar percentage return…you probably can’t think of anybody, right? This type of ROI is virtually unheard of and probably seems unbelievable to most people. But it’s 100% legitimate, and I want to share with you exactly how he did it. Just like any high-quality offering, it’s all about transparency.

So go grab a pen and paper because you’re about to get an Inside Look at how Kyle Dennis turned a small portfolio into millions within just a few short years. It’s only a matter of time before some of his students hit the 7-figure profit mark as well under his expert education and guidance.

Why the Biotech Sector Offers Massive Profit-Potential and You Should Be a Part of It:

First, you need to extinguish from your mind the thought that the returns Kyle Dennis has been experiencing are “unrealistic”. People tend to have this misguided belief that anything over a 10-20% annual return is impossible, but that couldn’t be further from the truth.

In fact, it’s very possible to capture 100% or even 1,000%+ by pursuing an effective trading strategy within the right niche. In Kyle Dennis’ case, he’s achieved a 20,000% return in less than five years pursuing a strategy he calls Biotech Catalyst Swing Trading. His entire approach is covered within his most popular program – FDA Insider Alerts.

It’s clear that the biotech industry is special. Not only has it outperformed the S&P 500 by nearly 2x over the past five years (IBB up 135% and SPY up 69%), but it’s simply more exciting. Overall, it’s an industry with enormous upside.

Here Are 3 Specific Reasons Why:

1) Overall Trend of the Sector: With the aging US population, the demand for effective drugs for all sorts of conditions is rising. Baby boomers need medical care as they approach the later stages of life, and they’re far from the only group that requires medical care. Every demographic, including Generation X, Millennials, and Generation Z, is impacted by various ailments and diseases. This guarantees an influx of new patients for decades to come.

2) Demand For Breakthrough Technology: Healthcare has come to the forefront of our society, and as a result, the demand for new, more effective medications has been growing exponentially. Biotech companies are constantly developing new technologies to prevent and treat diseases. They’re on the verge of achieving tremendous feats like curing cancer and editing human genes. Just imagine what type of result that can have on a stock when these types of breakthroughs are achieved.

3) Structured Drug Approval Process: Every single biotech or pharma company that wants to bring a new drug to market has to go through the same process. There are 3  primary trial periods that can act as catalysts: Phase I, Phase II, and Phase III. I won’t go into detail about what each one is, but essentially, they take place in order to prove that a treatment or drug is effective. When an exciting new drug is going through this process, it can create ideal opportunities for traders. Biotech stocks can tend to run-up into big events, especially if it’s for a condition that doesn’t currently have a cure.

Success In Biotech Trading Involves Learning and Mastering the Catalysts:

The Catalysts are the key to massive profits, and the biotech sector has no shortage of them. In all reality, the industry is a gold mine for those willing to do a little homework and position themselves in trades with substantial upside potential and low downside risk. The right catalysts paired with bullish chart patterns and some fundamental research can take your small portfolio and turn it into a large one at a rapid pace.

|BioPharmCatalyst.com Review – A Database of Opportunities For Biotech Traders|

One of Kyle’s “Secret Tools” for tracking these high-potential events is a platform called BioPharmCatalyst. It’s essentially a database of opportunities for biotech traders and investors, and the Biotech Breakouts community takes full advantage of what it has to offer. Many of these catalysts have the ability to double your investment on good data or cut it in half on bad data, so the stakes are high. Holding through such events isn’t the goal though, it’s too risky. The run-ups into the events offer plenty of opportunities for relatively safe, yet larger-than-normal profits. It all comes down to knowing exactly what to look for.

The 3-Step Process Kyle Dennis Routinely Follows to Reduce Risk and Increase Profits:

I’ve mentioned most aspects of Kyle’s Biotech Catalyst Swing Trading strategy already, but I want to provide some clarity on the exact process he uses to research, consider, and ultimately execute profitable trades.

Step 1 – Identify a Strong Catalyst

A catalyst or event is a reason for a stock to move. It can be anything ranging from an upcoming earnings release to a potential acquisition. In biotech stocks specifically, the various stages of drug approval like Phase I, II, and II can provide extremely tradable opportunities. Over the years, Kyle has found Phase II and III to be his favorites. The deeper a drug goes into the trial process, the more excitement and positive sentiment seems to materialize.

He also prefers catalysts with exact dates, and for good reason. When you know exactly when data will be released, it provides a specific timeframe for executing the trade. In other words, you can enter and exit the trade without putting yourself at risk of holding through the event itself. Again, the goal is to capitalize on the run-ups for massive profits, while reducing downside risk as much as possible.

Step 2 – Pair With a Bullish Trend or Pattern

A strong catalyst alone can substantially move a stock, but pairing with a bullish chart pattern helps increase the odds of success even further. The more reasons you can accumulate to back up your trade thesis, the better. Putting the risk-reward ratio in your favor is critical.

There’s a lot to study on the concept of technical analysis, but Kyle tends to keep it simple. In short, he charts basic horizontal support & resistance lines, looking to enter at support and sell at resistance. Essentially, support is a price level where buyers historically tend to come in, and resistance is a price range where sellers tend to show up. Without technical analysis, it’s mighty difficult to plan out your trades in terms of entries and exits. There are only a few reversal and momentum patterns that he looks for, so it’s simple for anybody to understand.

Step 3 – Perform Fundamental Research

The last step is to make sure the company is fundamentally sound. This step isn’t as important as it would be for long-term investors, for example, but even with 1-4 week hold times, you don’t want to get stuck in a Secondary Offering. This happens when a company doesn’t have enough money to fund operations, so they have to raise more through a financing. It’s not always a bad thing assuming the company uses the money to grow, but in the short-term it dilutes share price.

What Kyle does to avoid such situations is research cash position and burn rate. By doing so, he sidesteps one of the biggest risks associated with trading stocks. Lots of uninformed traders don’t look into these things, but Kyle does. He also digs into the company’s management team and how they’re compensated, press releases, drug pipelines, SEC filings, and more. Overall, he wants the trades he enters to be as safe as possible.

Real Examples of Biotech Catalyst Swing Trades:

Here’s where the money is made! These are real-life examples of Biotech Catalyst Swing Trades. Hopefully this provides you with a comprehensive view of how all these concepts come together. We’re talking about relatively short-term trades with massive upside potential and low downside risk. No holding through the events themselves. The run-ups provide plenty of opportunity by themselves.

ZGNX (Zogenix, Inc.)

Earlier this year, I started tracking ZGNX as it appeared on one of Kyle’s daily watch lists. It had solid support in the $8.00 range and an upcoming catalyst event (Phase II data to be released on one of their drugs) at some point in Q2. Plenty of cash so the likelihood of an offering was low. Some well-known institutional investors like Baker Brothers and Black Rock also held positions, which is typically a good sign. I was able to capture 13% on a Move From $8.40 to $9.50, and then another 10% on a Move From $9.19 to $10.25. A clear reversal pattern was beginning to form as I entered and ended up exiting for a massive 20%+ gain in roughly 1-2 weeks.

IMMU (Immunomedics, Inc.)

After being in Kyle’s service for over a year now, I know exactly what types of setups to look for without his help. I scouted IMMU on my own and Captured 6% on an Overnight Hold. It had much more strength to the upside following my exit, but it’s hard to pass up over 5% within a day. Having to decide when to take profits is a good problem to have. On 8/22, I noticed that this stock had been up-trending throughout the entire year, and with Phase II data due in early September, I figured we might have a run-up on our hands heading into the event. I entered my position on 8/23 at $9.55 and exited on 8/24 at $10.15 for a solid 6% gain. It eventually surpassed $12 just a few days later. Overall, it had over 30% profit potential within a couple weeks.

I can go on-and-on with the examples, but the point is that there are a ton of opportunities within the biotech sector on a daily, weekly, and monthly basis. Massive profits can be achieved while also keeping risk relatively low. It’s a volatile space to be in, but when you understand how it all works, you can put the odds in your favor on a consistent basis.

Best of all, it doesn’t matter if trial data is good or bad, or even if the companies you trade stay in business long-term. The profits are made on the run-ups into big events, simple as that. You enter, exit, and secure your profits within 1-4 weeks all before the events themselves even take place.

Service Offerings at Biotech Breakouts – Lightning Alerts, FDA Insider Alerts, and Nucleus:

Kyle Dennis currently offers three different service offerings under his Biotech Breakouts platform: Lightning Alerts, FDA Insider Alerts, and The Nucleus. Here are short explanations of what each one is all about.

Lightning Alerts: This service is mainly chat-based, which is perfect for active day and swing traders. Both Kyle Dennis and Keith Kern (Keith is previously from Trader’s Toolbox) teamed up to offer a state-of-the-art chat room focused on “lightning-fast” profits. This particular service doesn’t discriminate against any industry or sector. Whatever stocks are moving and have momentum, they have their eyes on for a potential play. Both traders provide their own separate watch lists on a daily basis, focusing on carefully-researched stocks with optimal technical setups. They alert every trade they make and utilize real-money portfolios.

This service is best for → Active Day & Swing Traders.

FDA Insider Alerts: This service focuses on Kyle’s #1 strategy, Biotech Catalyst Swing Trading. This strategy is the main driver behind him being able to Turn $15,000 Into Over $3,000,000 in under five years. The focus is solely on biotech stocks with upcoming catalysts, and finding technical and fundamental setups to match. There’s no such thing as a  “perfect” setup, but Kyle and his students are looking for a certain set of criteria. They attempt to isolate exciting events, position themselves in high-probability bullish chart patterns, and perform some fundamental background research in order to reduce risk. The ultimate goal is to capture massive gains on run-ups. These are typically 1-4 week hold times.

This service is best for → Busy Professionals & Swing Traders.

The Nucleus: This service is Kyle’s all-inclusive mentor service that provides access to Lightning Alerts, FDA Insider Alerts, and much more. The top feature of this program is Live Streaming Access to Kyle’s Portfolio, which allows for 100% transparency. It’s worth mentioning that there’s not many other traders out there willing to do this because they oftentimes have something to hide. Kyle, on the other hand, is willing to put every single move he makes on the table. In an industry full of “fakers” and “scam artists”, his complete transparency is refreshing. Overall, Kyle has a handful of strategies, or “profit buckets” as he likes to call them, that he implements in order to capture profits in the stock market, and this particular service uncovers all of them.

This service is best for → Committed Traders & Full-Time Traders.

Kyle Dennis’ Background and Track Record:

Kyle Dennis graduated from UCLA in 2012 with a degree in Biology. He incurred $80,000 in student loans and started working as a Real Estate Analyst making $35,000 per year. He was able to capture some solid profits trading part-time in 2013 and 2014, what many would consider a full-time income, but it wasn’t until 2015 when his profits exploded.

2013: $36,901 → 2014: $44,488 → 2015: $838,353 → 2016: $1,123,659 → 2017: $1,170,806 → 2018: $1,000,000+

It’s no surprise considering he joined an exclusive mentor service at that time being offered by Jason Bond. Kyle invested in himself and his own trading education, which eventually paid off thousands of times over. He took the concepts he learned from Jason and worked them into his own strategy within the biotech industry. He eventually quit his job that same year in order to pursue trading full-time. He then went on to launch his very own stock trading educational platform in 2016 – Biotech Breakouts. At this point in time (at only 27 years old), he’s making a consistent $1,000,000 per year in trading profits. Kyle’s Nucleus service resembles Jason’s Millionaire Roadmap.

Posts Featuring Kyle Dennis Before He Launched Biotech Breakouts:

|Millionaire Roadmap Client on Pace to Hit $1,000,000 in Trading Profits|

|Expert Stock Trading Mentor, Jason Bond, Awards Porsche to Millionaire Client|

|Millionaire Jason Bond Picks Client, Kyle Dennis, Launches Own Newsletter|

Special Bonus – Free Educational Webinars and E-Books From Kyle Dennis:

More than anything else, I want to help you find success in the stock market, and one of the best opportunities for free education is on Kyle’s Blog. He routinely records webinars on various topics related to his trading strategies and posts them for all to see. Members pay thousands of dollars for this material, in addition to daily watch lists, chat room access, special reports, and more, so these “freebies” provide an amazing opportunity for you to learn from the best biotech trader on Wall Street at no cost.

• September 8 Portfolio Summary Video
• Catalyst Trading and Charting Webinar Part 1
• Catalyst Trading and Charting Webinar Part 2
• Catalyst Trading and Charting Webinar Part 3
• Kyle’s Million-Dollar Biotech Playbook

Biotech Breakouts With Kyle Dennis Testimonials From Members:

Joining Kyle’s Biotech Breakouts service has revolutionized my trading experiences. As a new trader, I have learned so much from his educational material and from his live chats throughout the market hours. This especially has helped me tremendously as I learn what it takes to become a successful trader.

– Mario C.

Since upgrading to The Nucleus service I am up $4500 in two weeks of part time trading. Your chat room is extremely educational as you provide live Q&A commentary during the market. I feel confident that one day I will be able to do this for a living.

– Jose M.

Kyle, I want you to know that I appreciate and value the process of constructing trades that you are presenting. In my view, you take a calculated and patient approach to entering a trade & you are very patient & analytical about how you manage the trade. This reflects wisdom & experience, in my opinion.

– Bill W.

One of the things I so appreciate about you is the way you answer the same questions over and over without the least hint of impatience. Clearly, you have new people all the time and will get the same questions, but even so, you make each person feel like they are asking an important question that you are happy to address.

– Wanda H.

I signed up for BTB Nucleus program the day it was offered. Kyle spends all day in the chat room teaching. You have unrestricted access to get all of your questions answered. He will take time to discuss technicals, fundamentals, trade software, news programs, scanners, etc. I really enjoy this service, and it has led to some of my consistently highest success rates with a given trading technique. I intend to continue on with this service at the Nucleus level and highly recommend it to others.

– Heather M.

Make Biotech Catalyst Swing Trading Your “Go To” Strategy:

The greatest traders on Wall Street know how to gain an advantage. They put the odds in their favor and stick to a disciplined approach that allows them to capture profits on a consistent basis. They also tend to specialize, knowing that mastering a particular niche can be extremely lucrative. That’s exactly what Kyle Dennis has done with the biotech industry, and precisely how he’s been able to make millions in the market over the course of the last 5 years.

|Check Out the Original Biotech Breakouts With Kyle Dennis Review|

---

---

|3 Ways to Follow and Learn From Kyle Dennis (Millionaire Trader) For Free|

Most importantly, he’s willing to share his strategy with anyone willing to put the time and effort into it. He teaches a well-rounded strategy that took him a couple years to master, but it’s by far the most effective short-term swing trading strategy I’ve ever come across. There’s no reason why anybody can’t make this approach part of their normal routine. I can’t stress enough how many of his students have said that Kyle’s lessons allowed them to “turn a corner” in their trading. It’s time to see real results in your portfolio, and Biotech Breakouts can help you make it happen.

**2021 UPDATE** → Check Out My #1 Recommended Learning Program For Beginner and Intermediate Traders

Are You Ready to Fast-Track Your Trading Success With Kyle Dennis as Your Personal Mentor and Trading Coach? Get Started Now.

Written by Matt Thomas

Related Pages:

• BioTech Breakouts Review – Kyle Dennis Turned $15K Into Over $1M
• What is BioTech Breakouts? Capture Explosive Gains in Biotech Stocks
• Kyle Dennis’ Brokerage Account Now Streaming Live Within Biotech Nucleus
• How to Trade Biotech Stocks Successfully According to Kyle Dennis
• An Inside Look at How Kyle Dennis Turned $15K Into Nearly $2M